Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Market Cap : 3.847B for July 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 24, 2026 | 3.847B |
| July 23, 2026 | 3.847B |
| July 22, 2026 | 3.847B |
| July 21, 2026 | 3.847B |
| July 20, 2026 | 3.847B |
| July 17, 2026 | 3.847B |
| July 16, 2026 | 3.847B |
| July 15, 2026 | 3.847B |
| July 14, 2026 | 3.847B |
| July 13, 2026 | 3.846B |
| July 10, 2026 | 3.845B |
| July 09, 2026 | 3.845B |
| July 08, 2026 | 3.845B |
| July 07, 2026 | 3.847B |
| July 06, 2026 | 3.849B |
| July 02, 2026 | 3.843B |
| July 01, 2026 | 3.841B |
| June 30, 2026 | 3.840B |
| June 29, 2026 | 3.844B |
| June 26, 2026 | 3.849B |
| June 25, 2026 | 3.839B |
| June 24, 2026 | 3.839B |
| June 23, 2026 | 3.836B |
| June 22, 2026 | 3.834B |
| June 18, 2026 | 3.834B |
| Date | Value |
|---|---|
| June 17, 2026 | 3.836B |
| June 16, 2026 | 3.830B |
| June 15, 2026 | 3.833B |
| June 12, 2026 | 3.832B |
| June 11, 2026 | 3.833B |
| June 10, 2026 | 3.829B |
| June 09, 2026 | 3.829B |
| June 08, 2026 | 3.822B |
| June 05, 2026 | 3.821B |
| June 04, 2026 | 3.823B |
| June 03, 2026 | 3.822B |
| June 02, 2026 | 3.821B |
| June 01, 2026 | 3.821B |
| May 29, 2026 | 3.816B |
| May 28, 2026 | 3.823B |
| May 27, 2026 | 3.833B |
| May 26, 2026 | 3.834B |
| May 22, 2026 | 3.826B |
| May 21, 2026 | 3.828B |
| May 20, 2026 | 3.824B |
| May 19, 2026 | 3.820B |
| May 18, 2026 | 3.822B |
| May 15, 2026 | 3.816B |
| May 14, 2026 | 3.813B |
| May 13, 2026 | 3.813B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 106.63M |
| Indivior Pharmaceuticals, Inc. | 4.288B |
| Exelixis, Inc. | 13.96B |
| United Therapeutics Corp. | 22.12B |
| Krystal Biotech, Inc. | 10.38B |
Market Cap Related Metrics
| PE Ratio | 18.10 |
| PS Ratio | 6.712 |
| PEG Ratio | 1.642 |
| Price to Book Value | 3.799 |
| Price to Free Cash Flow | 19.25 |
| Price | 31.49 |
| Earnings Yield | 5.52% |
| PEGY Ratio | 1.642 |
| Operating PE Ratio | 14.97 |
| Normalized PE Ratio | 18.28 |